Breast Biopsy Devices Market Size and forecast to 2028

 

The global breast biopsy devices market size was valued at USD 9.4 billion in 2021, at a CAGR of 5.12% during the forecast period 2022-2028. The biopsy is one of the most common methods for diagnosing cancer diseases, and it is commonly employed in the diagnosis of breast, skin, and prostate cancer. It is an imaging tool in which tissue or fluid is removed from a questionable location. Working with a guidance system is required for the test, which is used to detect a lump or anomaly in the breast area. Mammography, Ultrasound, and magnetic resonance imaging are some of the many modalities used as guiding systems in the identification of breast cancers. Breast cancer, which is the most prevalent cancer in women throughout the globe, is caused by uncontrolled cell growth, which generally results in a lump.

View Detailed Report Description here https://precisionbusinessinsights.com/market-reports/global-breast-biopsy-devices-market/

Incidence of cancer and the elderly population are increasing in developing nations, posing substantial concerns. In Asian nations, conventional biopsy methods such as core-needle biopsies and surgical biopsies now lead the disease diagnostic market. Breast cancer has been the most prevalent cancer in women worldwide over the previous several years, as per GLOBOCAN figures, with somewhat higher instances in developing countries. Furthermore, breast cancer is the sixth greatest cause of mortality worldwide. To enhance efficiencies and reduced surgery costs, medical companies are increasingly focusing on integrating imaging technology with breast biopsy operations. Furthermore, rising knowledge of breast biopsy techniques is assisting in tapping the diagnostics sector in developing countries, allowing firms to engage in these provincial breast biopsy device markets.

The global breast biopsy devices market segmentation:

1) By Device type: Needles, Forceps, Guns, Others
2) Procedure type: Core needle biopsy, Vacuum-assisted core biopsy, Fine needle aspiration biopsy, Stereotactic core needle biopsy, Surgical biopsy, Others.
3) Guidance type: Ultrasound-guided biopsy, Magnetic resonance imaging (MRI) guided biopsy, Mammography guided stereotactic guided biopsy, Others.
4) End users: Hospitals, Clinics, Ambulatory surgical centres, Laboratories.

The market for breast biopsy instruments in North America is expected to grow at a significant CAGR of over the projected period. The increase in the market can be related to an increase in the occurrences of breast cancer, which is most often observed in females over 35 years of age following menopause, as well as increasing awareness of breast cancer screening programmes. Due to the growing healthcare infrastructure in rising nations such as China, South Korea and India, Asia-Pacific is anticipated to have substantial development from 2022 to 2028.

Request sample report https://precisionbusinessinsights.com/request-sample?product_id=17551   

There are several industry players working in the breast biopsy devices market, which include Medtronic, Inc. (Ireland), Becton, Dickinson and Company (U.S.), Hologic Inc. (U.S.), C.R. Bard, Inc. (U.S.), Planmed Oy (Finland), Scion Medical Technologies, LLC (U.S.), and Leica Biosystems (Danaher Corporation) to name a few.

 

About Precision Business Insights: 
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

 

Contact:

Mr. Satya

Precision Business Insights | Toll Free: +1 866 598 1553

Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174